文献速递结核与非结核分枝杆菌

高负担地区12剂异烟肼利福喷丁方案与6个月异烟肼方案治疗结核感染的经济成本比较

Cost of Delivering 12-Dose Isoniazid and Rifapentine Versus 6 Months of Isoniazid for Tuberculosis Infection in a High-Burden Setting.
PubMed 文献 · Clin Infect Dis · 2021-01-01

该研究在巴基斯坦卡拉奇高结核负担地区比较了3个月每周一次异烟肼联合利福喷丁(3HP)与6个月每日异烟肼(6H)用于结核预防治疗的经济成本。从项目与患者角度计算,每完成一个疗程的成本3HP为333美元,6H为394美元;采用2020年利福喷丁价格后3HP降至290美元。在所有情景假设下3HP每完成疗程成本均更低,主要成本驱动因素为临床人员薪资。

要点

  • 在高负担地区,3HP每完成疗程成本低于6H,主要得益于更高的治疗完成率。
  • 3HP完成率为61%,6H为39%;每完成疗程成本分别为333美元和394美元。
  • 采用2020年利福喷丁价格后,3HP每完成疗程成本降至290美元。

核心结论

  • 在高结核负担地区,成功交付3HP方案的成本低于6H方案,主要驱动因素是3HP的治疗完成率更高。

研究设计与样本

  • 研究开发了调查工具,从项目与患者来源收集成本,考虑从家庭接触者首次进入卫生系统时产生的费用。
  • 期间459人启动6H,643人启动3HP。

主要发现

  • 6H完成率为39%,3HP完成率为61%。
  • 考虑项目与受照护者双方成本,每完成疗程成本6H为394美元,3HP为333美元。
  • 使用2020年利福喷丁价格后,3HP每完成疗程成本降至290美元。
  • 在不同药物价格和受照护者成本假设下,3HP每完成疗程成本均更低,最大成本驱动因素为临床人员薪资。

临床怎么用

  • 在高负担地区推广3HP方案可能通过提高完成率降低每完成疗程的经济成本。
  • 项目规划时应考虑利福喷丁价格变动对3HP成本效益的影响。
  • 临床人员薪资是主要成本驱动因素,优化人力配置可能影响总体成本。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Successful delivery and completion of tuberculosis preventive treatment are necessary for tuberculosis elimination. Shorter preventive treatment regimens currently have higher medication costs, but patients spend less time in care and are more likely to complete treatment. It is unknown how economic costs of successful delivery differ between longer and shorter regimens in high-tuberculosis-burden settings. METHODS: We developed survey instruments to collect costs from program and patient sources, considering costs incurred from when household contacts first entered the health system. We compared the cost per completed course of preventive treatment with either 6 months of daily isoniazid (6H) or 3 months of weekly isoniazid and rifapentine (3HP), delivered by the Indus Health Network tuberculosis program in Karachi, Pakistan, between October 2016 and February 2018. RESULTS: During this period, 459 individuals initiated 6H and 643 initiated 3HP; 39% and 61% completed treatment, respectively. Considering costs to both the program and care recipients, the cost per completed course was 394 US dollars (USD) for 6H and 333 USD for 3HP. Using a new 2020 price for rifapentine reduced the cost per completed course of 3HP to 290 USD. Under varying assumptions about drug prices and costs incurred by care recipients, the cost per completed course was lower for 3HP in all scenarios, and the largest cost drivers were the salaries of clinical staff. CONCLUSIONS: In a high-burden setting, the cost of successful delivery of 3HP was lower than that of 6H, driven by higher completion.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Yuen CM, Majidulla A, Jaswal M, et al. Cost of Delivering 12-Dose Isoniazid and Rifapentine Versus 6 Months of Isoniazid for Tuberculosis Infection in a High-Burden Setting. Clin Infect Dis. 2021. PMID: 33289039. doi:10.1093/cid/ciaa1835

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。